Compounds > trovafloxacin
Page last updated: 2024-08-24

trovafloxacin and beta-lactams

trovafloxacin has been researched along with beta-lactams in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andriole, VT; Dembry, LM; Farrel, PA; Marino, SP; Roberts, JC; Schock, KD1
Seifert, H1
Alperstein, P; France, K; Isenberg, HD1
Bonner, D; Fung-Tomc, J; Gradelski, E; Kolek, B; Valera, L1
Goldstein, EJ1

Other Studies

5 other study(ies) available for trovafloxacin and beta-lactams

ArticleYear
Comparison of in vitro activity of trovafloxacin against gram-positive and gram-negative organisms with quinolones and beta-lactam antimicrobial agents.
    Diagnostic microbiology and infectious disease, 1998, Volume: 31, Issue:1

    Topics: 4-Quinolones; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Drug Evaluation, Preclinical; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Naphthyridines

1998
Comparative in-vitro activities of trovafloxacin, ciproflaxacin, ofloxacin, and broad-spectrum beta-lactams against aerobe blood culture isolates.
    Zentralblatt fur Bakteriologie : international journal of medical microbiology, 1998, Volume: 288, Issue:4

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Bacteria, Aerobic; Bacterial Infections; beta-Lactams; Blood; Culture Media; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Naphthyridines

1998
In vitro activity of ciprofloxacin, levofloxacin, and trovafloxacin, alone and in combination with beta-lactams, against clinical isolates of Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Burkholderia cepacia.
    Diagnostic microbiology and infectious disease, 1999, Volume: 33, Issue:2

    Topics: Anti-Infective Agents; beta-Lactams; Burkholderia cepacia; Ciprofloxacin; Fluoroquinolones; Humans; Levofloxacin; Naphthyridines; Ofloxacin; Pseudomonas aeruginosa; Xanthomonas

1999
Comparative killing kinetics of the novel des-fluoro(6) quinolone BMS-284756, fluoroquinolones, vancomycin and beta-lactams.
    International journal of antimicrobial agents, 2001, Volume: 18, Issue:1

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; beta-Lactams; Enterobacteriaceae; Enterococcus faecalis; Fluoroquinolones; Indoles; Kinetics; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Quinolones; Staphylococcus aureus; Streptococcus; Vancomycin

2001
Intra-abdominal anaerobic infections: bacteriology and therapeutic potential of newer antimicrobial carbapenem, fluoroquinolone, and desfluoroquinolone therapeutic agents.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, Sep-01, Volume: 35, Issue:Suppl 1

    Topics: Abdominal Abscess; Anti-Bacterial Agents; Aza Compounds; Bacteremia; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; beta-Lactams; Carbapenems; Clinical Trials as Topic; Ertapenem; Fluoroquinolones; Gemifloxacin; Humans; Indoles; Lactams; Moxifloxacin; Naphthyridines; Quinolines; Quinolones

2002